SCHEMBL42496

SCHEMBL42496

[O]CCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96488 0.87
SCHEMBL1699318 0.84
SCHEMBL8500348 0.84
SCHEMBL8500220 0.84
SCHEMBL2541524 0.84
SCHEMBL7857443 0.84
SCHEMBL8498984 0.84
SCHEMBL8497937 0.84
SCHEMBL2094653 0.84
SCHEMBL8500174 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4633 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348421-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) 2023-11-02 US claimed
CN-114728933-B 5-HT 2A Receptor inhibitor or inverse agonist, preparation method and application thereof 山东绿叶制药有限公司 2023-06-16 CN claimed
EP-4186893-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Geneora Pharma (Shijiazhuang) Co., Ltd. (CN) 2023-05-31 EP claimed
CN-114539269-B Nitrogen-containing macrocyclic compound, preparation method and application thereof 上海医药工业研究院有限公司 2023-04-28 CN claimed
CN-115894317-A Micromolecular compound with naphthylthiophenol ether structure and application thereof 杭州天玑济世生物科技有限公司 2023-04-04 CN claimed
CN-115894404-A Micromolecular compound with naphthylamine structure and application thereof 杭州天玑济世生物科技有限公司 2023-04-04 CN claimed
WO-2023045910-A1 SMALL-MOLECULE COMPOUND HAVING NAPHTHOL ETHER STRUCTURE, AND USE THEREOF 杭州天玑济世生物科技有限公司 2023-03-30 WO claimed
CN-114728933-A 5-HT2AReceptor inhibitor or inverse agonist, preparation method and application thereof 山东绿叶制药有限公司 2022-07-08 CN claimed
CN-114649584-A Electrolyte containing aromatic ring-type sulfur-based boron trifluoride salt and preparation method and application thereof 北京卫蓝新能源科技有限公司 2022-06-21 CN claimed
US-11345693-B2 Compounds, salts thereof and methods for treatment of diseases ACADIA PHARMACEUTICALS INC. (US) 2022-05-31 US claimed
EP-1575943-A1 3-CYANO-QUINOLINE DERIVATIVES AstraZeneca AB (SE) 2005-09-21 EP claimed
EP-1521751-A1 SUBSTITUTED 3-CYANOQUINOLINES AS MEK INHIBITORS Astrazeneca AB (SE) 2005-04-13 EP claimed
US-20040164272-A1 Dichoric mixture ROLIC AG (CH) 2004-08-26 US claimed
WO-2004041811-A1 3-CYANO-QUINOLINE DERIVATIVES ASTRAZENECA AB (SE) 2004-05-21 WO claimed
EP-1385914-A1 DICHROIC MIXTURE Rolic AG (CH) 2004-02-04 EP claimed
WO-2004005284-A1 SUBSTITUTED 3-CYANOQUINOLINES AS MEK INHIBITORS ASTRAZENECA AB (SE) 2004-01-15 WO claimed
WO-2002090447-A1 DICHROIC MIXTURE ROLIC AG (CH) 2002-11-14 WO claimed
EP-1256602-A1 Dichroic mixture Rolic AG (CH) 2002-11-13 EP claimed
US-6017931-A Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines FMC CORPORATION 2000-01-25 US claimed
US-5888475-A KIT FOR RAPID SYNTHESIS OF LABELED COCAINE DERIVATIVES THAT BIND DOPAMINE TRANSPORTER, COMPRISING SAID COCAINE DERIVATIVE, PHASE TRANSFER CATALYST, RADIOACTIVELY LABELED POTASSIUM FLUORIDE EMORY UNIVERSITY (US) 1999-03-30 US claimed